Complete Genomics (NASDAQ: GNOM) will sequence 1,000 genomes of healthy people in their 80s and up.

Mountain View, CA-based Complete Genomics (NASDAQ: GNOM) said earlier this month it will work with Scripps Health in San Diego to sequence 1,000 genomes of healthy people in their 80s and up, to look for the secrets to long, healthy life.

The trial, known as the “Wellderly Study,” will include 1,000 people who are “well” without any major diseases or long-term health complications, and “elderly,” from the ages of 80 through 108.

References

- Genomics 2.0: Ten Years After the Bubble, it’s Getting Really Interesting Again, Xconomy, 10/17/11